Link to this page
Drug Interaction Knowledge Base Ontology
Last uploaded:
May 19, 2015
Acronym | DIKB |
Visibility | Public |
Description | An evidence taxonomy for pharmacologic studies that, when combined with a set of inclusion criteria, enable drug experts to specify what their confidence in a drug mechanism assertion would be if it were supported by a specific set of evidence. Boyce R, Collins C, Horn J, Kalet I. Computing with evidence Part I: A drug-mechanism evidence taxonomy oriented toward confidence assignment. J Biomed Inform. 2009 Dec;42(6):979-89. Epub 2009 May 10. PubMed PMID: 19435613; PubMed Central PMCID: PMC2783801. |
Status | Beta |
Format | OWL |
Contact | Richard D Boyce, rdb20@pitt.edu |
Categories | Vocabularies |
Version | Released | Uploaded | Downloads |
---|---|---|---|
Version 1.6 (Parsed, Indexed, Metrics, Annotator) | 05/18/2015 | 05/19/2015 | OWL | CSV | RDF/XML | Diff |
Version 1.6 (Archived) | 05/18/2015 | 05/18/2015 | OWL | Diff |
The Dug Interaction Knowledge Base ontology. This version is essentially the original version from 2007 with a change to the base IRI to use a PURL (Archived) | 10/14/2011 | 02/09/2013 | OWL | Diff |
1.4 (Archived) | 10/14/2011 | 06/18/2012 | OWL | Diff |
0.2 (Archived) | 10/14/2011 | 10/14/2011 | OWL |
more... |
No views of DIKB available
Classes | 161 |
Individuals | 9 |
Properties | 138 |
Maximum depth | 4 |
Maximum number of children | 25 |
Average number of children | 2 |
Classes with a single child | 26 |
Classes with more than 25 children | 1 |
Classes with no definition | 14 |
Jump to:
Id | http://www.biopax.org/release/biopax-level3.owl#MolecularInteraction
http://www.biopax.org/release/biopax-level3.owl#MolecularInteraction
|
---|---|
Preferred Name | MolecularInteraction |
Definitions |
Definition: An interaction in which participants bind physically to each other,directly or indirectly through intermediary molecules.
Rationale: There is a large body of interaction data, mostly produced by high throughput systems, that does not satisfy the level of detail required to model them with ComplexAssembly class. Specifically, what is lacking is the stoichiometric information and completeness ( closed-world) of participants required to model them as chemical processes. Nevertheless interaction data is extremely useful and can be captured in BioPAX using this class.
Usage: This class should be used by default for representing molecular interactions, such as those defined by PSI-MI level 2.5. The participants in a molecular interaction should be listed in the PARTICIPANTS slot. Note that this is one of the few cases in which the PARTICPANT slot should be directly populated with instances (see comments on the PARTICPANTS property in the interaction class description). If all participants are known with exact stoichiometry, ComplexAssembly class should be used instead.
Example: Two proteins observed to interact in a yeast-two-hybrid experiment where there is not enough experimental evidence to suggest that the proteins are forming a complex by themselves without any indirect involvement of other proteins. This is the case for most large-scale yeast two-hybrid screens.
Definition: An interaction in which participants bind physically to each other, directly or indirectly through intermediary molecules.
Rationale: There is a large body of interaction data, mostly produced by high throughput systems, that does not satisfy the level of detail required to model them with ComplexAssembly class. Specifically, what is lacking is the stoichiometric information and completeness (closed-world) of participants required to model them as chemical processes. Nevertheless interaction data is extremely useful and can be captured in BioPAX using this class.
Usage: This class should be used by default for representing molecular interactions such as those defined by PSI-MI level 2.5. The participants in a molecular interaction should be listed in the PARTICIPANT slot. Note that this is one of the few cases in which the PARTICPANT slot should be directly populated with instances (see comments on the PARTICPANTS property in the interaction class description). If all participants are known with exact stoichiometry, ComplexAssembly class should be used instead.
Example: Two proteins observed to interact in a yeast-two-hybrid experiment where there is not enough experimental evidence to suggest that the proteins are forming a complex by themselves without any indirect involvement of other proteins. This is the case for most large-scale yeast two-hybrid screens.
|
Type | http://www.w3.org/2002/07/owl#Class |
All Properties
comment | Definition: An interaction in which participants bind physically to each other,directly or indirectly through intermediary molecules.
Rationale: There is a large body of interaction data, mostly produced by high throughput systems, that does not satisfy the level of detail required to model them with ComplexAssembly class. Specifically, what is lacking is the stoichiometric information and completeness ( closed-world) of participants required to model them as chemical processes. Nevertheless interaction data is extremely useful and can be captured in BioPAX using this class.
Usage: This class should be used by default for representing molecular interactions, such as those defined by PSI-MI level 2.5. The participants in a molecular interaction should be listed in the PARTICIPANTS slot. Note that this is one of the few cases in which the PARTICPANT slot should be directly populated with instances (see comments on the PARTICPANTS property in the interaction class description). If all participants are known with exact stoichiometry, ComplexAssembly class should be used instead.
Example: Two proteins observed to interact in a yeast-two-hybrid experiment where there is not enough experimental evidence to suggest that the proteins are forming a complex by themselves without any indirect involvement of other proteins. This is the case for most large-scale yeast two-hybrid screens.
Definition: An interaction in which participants bind physically to each other, directly or indirectly through intermediary molecules.
Rationale: There is a large body of interaction data, mostly produced by high throughput systems, that does not satisfy the level of detail required to model them with ComplexAssembly class. Specifically, what is lacking is the stoichiometric information and completeness (closed-world) of participants required to model them as chemical processes. Nevertheless interaction data is extremely useful and can be captured in BioPAX using this class.
Usage: This class should be used by default for representing molecular interactions such as those defined by PSI-MI level 2.5. The participants in a molecular interaction should be listed in the PARTICIPANT slot. Note that this is one of the few cases in which the PARTICPANT slot should be directly populated with instances (see comments on the PARTICPANTS property in the interaction class description). If all participants are known with exact stoichiometry, ComplexAssembly class should be used instead.
Example: Two proteins observed to interact in a yeast-two-hybrid experiment where there is not enough experimental evidence to suggest that the proteins are forming a complex by themselves without any indirect involvement of other proteins. This is the case for most large-scale yeast two-hybrid screens.
|
---|---|
prefLabel | MolecularInteraction
|
prefixIRI |
MolecularInteraction
bp:MolecularInteraction
|
subClassOf | |
type |
Add comment
Delete | Subject | Author | Type | Created |
---|---|---|---|---|
No notes to display |
- Problem retrieving properties:
Notes
Filter: